Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Tuesday, October 19, 2021
Aptar CSP Technologies, part of AptarGroup, Inc., and a leader in active material science solutions that ensure product protection, extend shelf life and improve user experience, was awarded a $19 million contract from the U.S. government. This award...
read more
Thursday, September 08, 2022
Aptar Pharma has acquired Metaphase Design Group, a leader in applying the science of human factors engineering and ergonomics to product design.
read more
Wednesday, November 04, 2020
AptarGroup has acquired all operating assets and the proprietary portfolio of Cohero Health.
read more
Wednesday, October 27, 2021
Aptar Pharma, a global leader in drug delivery systems, services and active material science solutions, and i2c Pharmaceutical Services, a leading service provider for the development of pharmaceutical formulations, today announced an exclusive ...
read more
Aptar Pharma, part of AptarGroup, Inc., announced the next phase of its global capacity expansion plan in North America, at its Aptar Congers, New York site.
read more
Tuesday, October 26, 2021
Aptar Pharma, a global leader in drug delivery systems, services and active material science solutions, announced an exclusive partnership with Stallergenes Greer, a global healthcare company specializing in allergen immunotherapy (AIT), for the ...
read more
Aptar Pharma acquired worldwide rights to Pharmaxis’ proprietary Orbital™ inhaler, a unique device that can deliver high payload dry powder to the lungs.
read more
Aptar Pharma, a global leader in drug delivery systems, services and active material science solutions, today announced that they have entered into an agreement with Pharmaxis, a clinical stage drug developer, under which Aptar Pharma has the option ...
read more
Monday, November 25, 2019
Aptar Pharma has announced its preservative-free multidose Ophthalmic Squeeze Dispenser is the delivery system for Allergan’s REFRESH® RELIEVA™ PF.
read more
AptarGroup is seeking FDA Emergency Use Authorization for a solution that allows easy disinfecting of N95 filtering facepiece respirators.
read more
AptarGroup and Sonmol have announced a collaboration for developing a digital therapies and services platform targeting respiratory and other diseases.
read more
AptarGroup announced that its proprietary nasal delivery system is being utilized in LTR Pharma Limited’s Phase II clinical study of SPONTAN®, an investigational intranasal spray under development for the treatment of erectile dysfunction.
read more
Aptuit, LLC has acquired Exquiron Biotech AG to meet customer demand for fully integrated outsourced discovery services. Exquiron is a leading specialist Contract Research Organization dedicated to early phase drug discovery solutions.
read more
Aptuit has acquired Kuecept Ltd to meet strong customer demand for specialist drug pre-formulation, formulation prototyping and formulation development services.
read more
Wednesday, January 04, 2017
Aptuit and Chiesi Farmaceutici have entered an agreement under which Aptuit will conduct an integrated Discovery Project aimed at providing innovative drugs to treat Idiopathic Pulmonary Fibrosis.
read more